LINDA R ALTEMUS Insider Trading $WST WEST PHARMACEUTICAL SERVICES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LINDA R ALTEMUS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LINDA R ALTEMUS. LINDA R ALTEMUS is VP & CFO in WEST PHARMACEUTICAL SERVICES INC ($WST) and VP & Chief Compliance Officer in WEST PHARMACEUTICAL SERVICES INC ($WST).
LINDA R ALTEMUS in WEST PHARMACEUTICAL SERVICES INC
Industry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of LINDA R ALTEMUS: VP & Chief Compliance Officer, VP & CFO
Holdings: 4,547 shares
Current Value: $389,496
Latest Transaction: Jan 30 2006
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LINDA R ALTEMUS in WEST PHARMACEUTICAL SERVICES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2006 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 30.92 | 10 | 309 | 4,547 | 4.5 K to 4.5 K (+0.22 %) |
| Jan 18 2006 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 28.22 | 11 | 310 | 4,539 | 4.5 K to 4.5 K (+0.24 %) |
| Jan 03 2006 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 25.03 | 12 | 300 | 4,517 | 4.5 K to 4.5 K (+0.27 %) |
| Dec 20 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 24.50 | 12 | 294 | 4,504 | 4.5 K to 4.5 K (+0.27 %) |
| Dec 05 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 25.67 | 12 | 308 | 4,492 | 4.5 K to 4.5 K (+0.27 %) |
| Nov 22 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 25.89 | 12 | 311 | 4,479 | 4.5 K to 4.5 K (+0.27 %) |
| Nov 07 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 23.78 | 13 | 309 | 4,565 | 4.6 K to 4.6 K (+0.29 %) |
| Oct 24 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 23.27 | 13 | 303 | 4,552 | 4.5 K to 4.6 K (+0.29 %) |
| Oct 11 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 28.38 | 11 | 312 | 4,418 | 4.4 K to 4.4 K (+0.25 %) |
| Sep 26 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 29.05 | 10 | 291 | 4,406 | 4.4 K to 4.4 K (+0.23 %) |
| Sep 12 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 29.05 | 10 | 291 | 4,396 | 4.4 K to 4.4 K (+0.23 %) |
| Aug 30 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 26.80 | 11 | 295 | 4,387 | 4.4 K to 4.4 K (+0.25 %) |
| Aug 16 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 26.62 | 11 | 293 | 4,377 | 4.4 K to 4.4 K (+0.25 %) |
| Aug 02 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 27.24 | 11 | 300 | 4,365 | 4.4 K to 4.4 K (+0.25 %) |
| Jul 19 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 27.86 | 11 | 306 | 4,335 | 4.3 K to 4.3 K (+0.25 %) |
| Jul 06 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 28.10 | 11 | 309 | 4,324 | 4.3 K to 4.3 K (+0.26 %) |
| Jun 07 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 27.43 | 11 | 302 | 4,302 | 4.3 K to 4.3 K (+0.26 %) |
| Jun 20 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 28.44 | 11 | 313 | 4,313 | 4.3 K to 4.3 K (+0.26 %) |
| May 24 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 28.10 | 11 | 309 | 4,291 | 4.3 K to 4.3 K (+0.26 %) |
| May 10 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 27.75 | 11 | 305 | 4,281 | 4.3 K to 4.3 K (+0.26 %) |
| May 05 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 13.38 | 10,000 | 133,750 | 10,000 | |
| May 05 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Sell | S | 27.15 | 10,000 | 271,450 | 23,411 | 33.4 K to 23.4 K (-29.93 %) |
| May 05 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 13.38 | 10,000 | 133,750 | 33,411 | 23.4 K to 33.4 K (+42.71 %) |
| Apr 26 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 26.61 | 11 | 293 | 4,272 | 4.3 K to 4.3 K (+0.26 %) |
| Apr 11 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 23.90 | 12 | 287 | 4,244 | 4.2 K to 4.2 K (+0.28 %) |
| Mar 28 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 23.71 | 13 | 308 | 4,232 | 4.2 K to 4.2 K (+0.31 %) |
| Mar 28 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Sell | S | 25.71 | 1,500 | 38,565 | 20,478 | 22 K to 20.5 K (-6.83 %) |
| Mar 16 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 24.09 | 13 | 313 | 4,219 | 4.2 K to 4.2 K (+0.31 %) |
| Mar 09 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | A | 25.53 | 11,000 | 280,830 | 11,000 | |
| Mar 09 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 25.57 | 1,187 | 30,352 | 4,206 | 3 K to 4.2 K (+39.32 %) |
| Mar 09 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 0.00 | 2,885 | 0 | 24,911 | 22 K to 24.9 K (+13.10 %) |
| Feb 28 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 25.85 | 12 | 310 | 3,020 | 3 K to 3 K (+0.40 %) |
| Feb 14 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 26.32 | 10 | 263 | 3,007 | 3 K to 3 K (+0.33 %) |
| Jan 31 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 25.81 | 12 | 310 | 2,997 | 3 K to 3 K (+0.40 %) |
| Jan 19 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 13.02 | 4,000 | 52,063 | 0 | |
| Jan 19 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 13.02 | 4,000 | 52,063 | 21,901 | 17.9 K to 21.9 K (+22.35 %) |
| Jan 12 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 13.02 | 5,000 | 65,079 | 4,000 | |
| Jan 12 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Sell | M | 25.52 | 5,000 | 127,600 | 17,901 | 22.9 K to 17.9 K (-21.83 %) |
| Jan 12 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 13.02 | 5,000 | 65,079 | 22,901 | 17.9 K to 22.9 K (+27.93 %) |
| Jan 03 2005 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 25.03 | 11 | 275 | 2,961 | 3 K to 3 K (+0.37 %) |
| Dec 21 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 23.50 | 13 | 306 | 2,917 | 2.9 K to 2.9 K (+0.45 %) |
| Dec 06 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 23.45 | 13 | 305 | 2,904 | 2.9 K to 2.9 K (+0.45 %) |
| Nov 22 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 22.86 | 13 | 297 | 2,891 | 2.9 K to 2.9 K (+0.45 %) |
| Nov 09 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 22.92 | 13 | 298 | 2,878 | 2.9 K to 2.9 K (+0.45 %) |
| Oct 26 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 21.82 | 14 | 305 | 2,865 | 2.9 K to 2.9 K (+0.49 %) |
| Oct 12 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 21.27 | 14 | 298 | 2,852 | 2.8 K to 2.9 K (+0.49 %) |
| Sep 27 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 39.00 | 8 | 312 | 751 | 743 to 751 (+1.08 %) |
| Sep 13 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 40.05 | 7 | 280 | 743 | 736 to 743 (+0.95 %) |
| Aug 30 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 39.88 | 7 | 279 | 736 | 729 to 736 (+0.96 %) |
| Aug 16 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 36.95 | 8 | 296 | 729 | 721 to 729 (+1.11 %) |
| Aug 02 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 38.09 | 8 | 305 | 720 | 712 to 720 (+1.12 %) |
| Jul 19 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 40.21 | 7 | 281 | 709 | 702 to 709 (+1.00 %) |
| Jul 06 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 42.68 | 7 | 299 | 701 | 694 to 701 (+1.01 %) |
| Jul 01 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 40.88 | 3,763 | 153,831 | 9,552 | 5.8 K to 9.6 K (+65.00 %) |
| Jun 21 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 40.10 | 7 | 281 | 694 | 687 to 694 (+1.02 %) |
| Jun 07 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 37.48 | 8 | 300 | 687 | 679 to 687 (+1.18 %) |
| May 24 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 37.55 | 8 | 300 | 679 | 671 to 679 (+1.19 %) |
| May 11 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 38.50 | 7 | 270 | 671 | 664 to 671 (+1.05 %) |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | A | 38.73 | 7,300 | 282,729 | 7,300 | |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 0.00 | 1,937 | 0 | 5,789 | 3.9 K to 5.8 K (+50.29 %) |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 36.50 | 967 | 35,296 | 3,852 | 2.9 K to 3.9 K (+33.52 %) |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 32.84 | 400 | 13,138 | 0 | |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 32.84 | 2,165 | 71,107 | 400 | |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 32.84 | 400 | 13,138 | 2,885 | 2.5 K to 2.9 K (+16.10 %) |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Sell | S | 39.20 | 2,165 | 84,857 | 2,485 | 4.7 K to 2.5 K (-46.56 %) |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 32.84 | 2,165 | 71,107 | 4,650 | 2.5 K to 4.7 K (+87.12 %) |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 32.84 | 400 | 13,138 | 0 | |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 32.84 | 2,165 | 71,107 | 400 | |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 32.84 | 400 | 13,138 | 2,885 | 2.5 K to 2.9 K (+16.10 %) |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Sell | S | 39.20 | 2,165 | 84,857 | 2,485 | 4.7 K to 2.5 K (-46.56 %) |
| Apr 28 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 32.84 | 2,165 | 71,107 | 4,650 | 2.5 K to 4.7 K (+87.12 %) |
| Apr 26 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 39.14 | 7 | 274 | 660 | 653 to 660 (+1.07 %) |
| Apr 12 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 38.80 | 7 | 272 | 653 | 646 to 653 (+1.08 %) |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Option Exercise | M | 32.84 | 1,935 | 63,553 | 2,565 | |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Payment of Exercise | F | 37.37 | 1,700 | 63,521 | 2,485 | 4.2 K to 2.5 K (-40.62 %) |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Payment of Exercise | F | 37.37 | 83 | 3,101 | 4,185 | 4.3 K to 4.2 K (-1.94 %) |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Buy | M | 32.84 | 1,935 | 63,553 | 4,268 | 2.3 K to 4.3 K (+82.94 %) |
| Mar 29 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 36.13 | 8 | 289 | 646 | 638 to 646 (+1.25 %) |
| Mar 16 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 36.37 | 8 | 291 | 638 | 630 to 638 (+1.27 %) |
| Mar 02 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 36.88 | 8 | 295 | 630 | 622 to 630 (+1.29 %) |
| Feb 17 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 36.15 | 8 | 289 | 622 | 614 to 622 (+1.30 %) |
| Feb 02 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 35.60 | 8 | 285 | 614 | 606 to 614 (+1.32 %) |
| Jan 20 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 35.41 | 8 | 283 | 603 | 595 to 603 (+1.34 %) |
| Jan 06 2004 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 34.08 | 8 | 273 | 594 | 586 to 594 (+1.37 %) |
| Dec 22 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 35.01 | 8 | 280 | 586 | 578 to 586 (+1.38 %) |
| Dec 08 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 33.92 | 8 | 271 | 578 | 570 to 578 (+1.40 %) |
| Nov 21 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 32.42 | 9 | 292 | 569 | 560 to 569 (+1.61 %) |
| Nov 10 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 34.95 | 8 | 280 | 561 | 553 to 561 (+1.45 %) |
| Oct 27 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 31.50 | 9 | 284 | 549 | 540 to 549 (+1.67 %) |
| Oct 15 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 32.80 | 9 | 295 | 540 | 531 to 540 (+1.69 %) |
| Sep 29 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 31.99 | 9 | 288 | 531 | 522 to 531 (+1.72 %) |
| Sep 29 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 31.99 | 9 | 288 | 531 | 522 to 531 (+1.72 %) |
| Sep 15 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 31.88 | 9 | 287 | 522 | 513 to 522 (+1.75 %) |
| Sep 02 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & Chief Complian ... | Grant | A | 27.90 | 10 | 279 | 513 | 503 to 513 (+1.99 %) |
| Aug 18 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & CFO | Grant | A | 26.62 | 11 | 293 | 503 | 492 to 503 (+2.24 %) |
| Aug 04 2003 | WST | WEST PHARMACEUTICA ... | ALTEMUS LINDA R | VP & CFO | Grant | A | 27.21 | 11 | 299 | 492 | 481 to 492 (+2.29 %) |
Page: 1